Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zhongyu Yuan"'
Autor:
Xiaoyu Teng, Donggen Liu, Tao Qin, Yanxia Shi, Zhongyu Yuan, Cong Xue, Shusen Wang, Roujun Peng, Li Zhang, Xi Wang
Publikováno v:
Cancer Science
Breast cancer research and treatment by different subtypes is an inevitable trend. We investigated the clinicopathologic features and outcomes of different breast cancer subtypes in Southern China. A total of 5809 patients with invasive ductal carcin
Autor:
Xiaoyu Teng, Shusen Wang, Yuting Tan, Dong-Geng Liu, Ying Jin, Xiuyu Cai, Xin An, Roujun Peng, Zhongyu Yuan, Yanxia Shi, Ye Cao, Yue-Li Sun
Publikováno v:
Medical Oncology. 29:39-47
Trastuzumab has been the standard treatment in first-line treatment of HER-2-positive advanced breast cancer (H2ABC). This study explored whether the delayed and repeated use of trastuzumab could influence overall survival (OS). A total of 128 patien
Publikováno v:
Medical Oncology. 30
The aim of this study was to evaluate the prognostic value of light chain 3 (LC3) expression in triple-negative breast cancer (TNBC) and describe the association of LC3 expression with the occurrence of metastasis. LC3 expression in tissue microarray
Autor:
Tao Qin, Roujun Peng, Xiaoyu Teng, Jie-Wen Peng, Donggen Liu, Yanxia Shi, Xi Wang, Xiaomei Jiang, Gui-Nan Lin, Zhongyu Yuan, Shusen Wang
Publikováno v:
Medical oncology (Northwood, London, England). 29(2)
Patients suffering from triple-negative breast cancer (TNBC) have poor prognosis mainly because no standard treatment is currently available. Our objectives were to explore the prognostic factors for first relapse of patients with TNBC. A cohort of 6